At last getting news out to the public. Last paragraph of article, Ventracor speaking at conference.http://www.ferret.com.au/articles/f8/0c040af8.asp
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%